Activities of daily living and health status benefits of semaglutide in very old patients with heart failure, type 2 diabetes, and obesity: Real-world practice study.
A recently indexed PubMed record relevant to peptide research. The displayed date may reflect indexing rather than final print publication. Review the original citation and study limitations.
Open original source ↗Collected Oct 31, 2026. Third-party data may change. Consult the original publication or registry for complete methods, findings and status.